deoxycytidine has been researched along with Medulloblastoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Campagne, O; Jonchere, B; Liu, J; Northcott, PA; Onar-Thomas, A; Patel, Y; Pribnow, A; Robinson, GW; Robinson, S; Roussel, MF; Smith, KS; Stewart, CF; Wu, G; Xu, K; Yu, J | 1 |
| Balakrishnan, I; Desisto, J; Eberhardt, CG; Foreman, NK; Green, A; Griesinger, A; Moreira, DC; Pierce, A; Prince, E; Subramanian, A; Venkataraman, S; Vibhakar, R | 1 |
| Beilhack, A; Caruana, I; Miele, E; Mokhtari, Z; Schlegel, PG; Schneider, T; Schwinn, S; Sirén, AL; Thusek, S; Tiemeyer, N; Wölfl, M | 1 |
| de Martino, M; Facchini, L; Farina, S; Lucchesi, M; Materassi, M; Melosi, F; Roperto, RM; Sardi, I; Stival, A; Tintori, V | 1 |
| Bauer, D; Biassoni, V; Casanova, M; Catania, S; De Pava, MV; Gandola, L; Indini, A; Massimino, M; Modena, P; Pecori, E; Podda, M; Polastri, D; Rampini, P; Schiavello, E | 1 |
| Ayrault, O; Bihannic, L; Finkelstein, D; Freeman, BB; Gajjar, A; Guy, RK; Jacus, M; Li, XN; Morfouace, M; Olson, JM; Puget, S; Robinson, GW; Robinson, S; Roussel, MF; Shelat, A; Stewart, CF; Turner, D; Wang, YD; Zindy, F | 1 |
| Grigull, L; Hartmann, C; Linderkamp, C; Reinhardt, D; Sander, A; Schmid, H; Weinel, P; Welte, K | 1 |
| Aftab, BT; Campbell, NR; Chenna, V; Hong, SM; Hu, C; Karikari, C; Khan, SR; Maitra, A; Pramanik, D; Rudek, MA; Rudin, CM; Zhao, M | 1 |
8 other study(ies) available for deoxycytidine and Medulloblastoma
| Article | Year |
|---|---|
Combination of Ribociclib and Gemcitabine for the Treatment of Medulloblastoma.
Topics: Aminopyridines; Animals; Cerebellar Neoplasms; Child; Deoxycytidine; Gemcitabine; Humans; Medulloblastoma; Mice; Purines | 2022 |
Targeting MYC-driven replication stress in medulloblastoma with AZD1775 and gemcitabine.
Topics: Animals; Antineoplastic Agents; Cell Cycle Proteins; Cell Line, Tumor; Cerebellar Neoplasms; Deoxycytidine; Enzyme Inhibitors; Female; Gemcitabine; Genes, myc; Humans; Medulloblastoma; Mice, Transgenic; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidinones | 2020 |
Cytotoxic effects and tolerability of gemcitabine and axitinib in a xenograft model for c-myc amplified medulloblastoma.
Topics: Animals; Antineoplastic Agents; Axitinib; Cell Line, Tumor; Cell Survival; Deoxycytidine; Disease Models, Animal; Drug Resistance, Neoplasm; Gemcitabine; Gene Amplification; Gene Expression; Humans; Medulloblastoma; Mice; Neovascularization, Pathologic; Proto-Oncogene Proteins c-myc; Receptors, Vascular Endothelial Growth Factor; Treatment Outcome; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2021 |
Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report.
Topics: Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Cerebellar Neoplasms; Child, Preschool; Complement Inactivating Agents; Deoxycytidine; Fatal Outcome; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Medulloblastoma | 2017 |
Relapse in medulloblastoma: what can be done after abandoning high-dose chemotherapy? A mono-institutional experience.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Cerebellar Neoplasms; Child; Child, Preschool; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cranial Irradiation; Dacarbazine; Deoxycytidine; Disease Progression; Disease-Free Survival; Etoposide; Female; Gemcitabine; Humans; Irinotecan; Male; Medulloblastoma; Melphalan; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Patient Selection; Quality of Life; Radiotherapy; Retrospective Studies; Salvage Therapy; Temozolomide; Young Adult | 2013 |
Pemetrexed and gemcitabine as combination therapy for the treatment of Group3 medulloblastoma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cerebellar Neoplasms; Deoxycytidine; Gemcitabine; Glutamates; Guanine; High-Throughput Screening Assays; Humans; Medulloblastoma; Mice; Mice, Transgenic; Pemetrexed; Prognosis | 2014 |
Oxaliplatin, irinotecan, and gemcitabine: a novel combination in the therapy of progressed, relapsed, or refractory tumors in children.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Neuroendocrine; Central Nervous System Neoplasms; Cerebellar Neoplasms; Child; Child, Preschool; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Irinotecan; Lung Neoplasms; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroblastoma; Organoplatinum Compounds; Osteosarcoma; Oxaliplatin; Retrospective Studies; Treatment Outcome | 2011 |
A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonists.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Hedgehog Proteins; Humans; Male; Medulloblastoma; Mice; Mice, Nude; Nanoparticles; Pancreatic Neoplasms; Patched Receptors; Patched-1 Receptor; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Signal Transduction; Smoothened Receptor; Transcription Factors; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2012 |